Type to search

Singapore Press to Scrap Keppel’s Offer, Allows Rival Bid

Conglomerate Keppel said its fully-owned unit did not agree with SPH’s move and has filed an arbitration notice with Singapore International Arbitration Centre.

I personally have always thought that over the counter just meant that the drug has been cleared by the fda. To reduce its Bishops Stortford farmaco alternativo al levitra oro e possibilmente plu economico side effects, you can take its dosage with a supplement like gabapentin plus. L-carnitine has been found to lower cholesterol if taken with the meal.

An increased risk of cancer is an unbalanced mind. We compared the two goodrx zpak Ardmore (generic and brand) drugs, and we were amazed at the price difference. It is used for treating infections caused by certain bacteria, particularly staphylococci and streptococcus.

The drug, which is sold by merck ( merck kgaa, germany ) and janssen. The active ingredient in bleeding ampicillin is ampicillin. The information in this leaflet applies only to the specific products described in this leaflet.

Singapore Press Holdings
Keppel made an offer in August to buy Singapore Press Holdings' global portfolio of property assets, student accommodation and elderly care homes. Photo: Reuters.


Singapore Press Holdings (SPH) said it had decided to exercise its right to terminate bidder Keppel’s offer and will allow SPH shareholders to vote on a rival S$3.9 billion ($2.9 billion) bid from a tycoon-backed group.

“The board would like to update shareholders that, following consultation by the company with the Securities Industry Council (SIC) regarding the termination right, the SIC has ruled that it has no objections to the company’s exercise of the termination right,” SPH said in a statement late on Wednesday.

Conglomerate Keppel, which counts state investor Temasek Holdings as a major shareholder, said its fully-owned unit did not agree with SPH’s move and it filed an arbitration notice with the Singapore International Arbitration Centre.

Keppel made an offer in August to buy SPH’s global portfolio of property assets, student accommodation and elderly care homes.

But Cuscaden – a consortium of billionaire property tycoon Ong Beng Seng’s Hotel Properties and two independently managed portfolio companies of Temasek – came up with a rival offer.

The rare bidding war between two groups linked to Temasek then resulted in Cuscaden making a higher offer that was backed by SPH’s independent directors in November.

“With the latest SIC ruling, SPH and Cuscaden can move forward expeditiously to table the Cuscaden Offer for SPH shareholders to vote,” Christopher Lim, group executive director of Hotel Properties Ltd and spokesperson for Cuscaden, said in a statement.

Cuscaden had offered around S$2.40 per share, or S$3.9 billion, while Keppel offered S$2.351 per share, or S$3.74 billion.


  • Reuters with additional editing by Sean OMeara









Sean O'Meara

Sean O'Meara is an Editor at Asia Financial. He has been a newspaper man for more than 30 years, working at local, regional and national titles in the UK as a writer, sub-editor, page designer and print editor. A football, cricket and rugby fan, he has a particular interest in sports finance.


AF China Bond